GSK

33.78

1.05% 0.35

Dopo l'orario di chiusura: 33.78

Gsk Plc Adr (GSK)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$33.43

Aprire:

$33.57

Volume 24 ore:

3.88M

Relative Volume:

0.74

Capitalizzazione di mercato:

$68.92B

Reddito:

$39.71B

Utile/perdita netta:

$3.17B

Rapporto P/E:

21.96

EPS:

1.5382

Flusso di cassa netto:

$6.05B

1 W Prestazione:

+5.30%

1M Prestazione:

+0.54%

6M Prestazione:

-14.16%

1 anno Prestazione:

-14.87%

Intervallo 1D:

$33.53

$33.79

Intervallo di 1 settimana:

$32.51

$33.79

Portata 52W:

$31.71

$45.92

Gsk Plc Adr Stock (GSK) Company Profile

Nome

Gsk Plc Adr

Settore

Healthcare (1194)

Industria

Drug Manufacturers - General (19)

Telefono

Indirizzo

Dipendente

70,200

Cinguettio

@GSK

Prossima data di guadagno

2024-10-30

Ultimi documenti SEC

GSK's Discussions on Twitter

Confronta GSK con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GSK Gsk Plc Adr	33.78	68.92B	39.71B	3.17B	6.05B	1.5382
LLY Lilly Eli Co	742.35	705.53B	40.86B	8.37B	-2.28B	9.25
NVO Novo Nordisk Adr	81.03	359.79B	39.36B	13.79B	9.83B	3.086
JNJ Johnson Johnson	148.15	344.63B	87.70B	14.68B	19.03B	6.05
ABBV Abbvie Inc	172.61	305.03B	55.53B	5.12B	15.62B	2.88
MRK Merck Co Inc	96.24	251.88B	63.17B	12.15B	14.84B	4.77

Gsk Plc Adr Stock (GSK) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-11-15	Downgrade	Deutsche Bank	Buy → Hold
2024-11-12	Downgrade	Jefferies	Buy → Hold
2024-10-31	Downgrade	Guggenheim	Buy → Neutral
2024-07-08	Downgrade	UBS	Buy → Neutral
2024-05-30	Iniziato	Goldman	Neutral
2024-03-04	Aggiornamento	Guggenheim	Neutral → Buy
2024-02-13	Aggiornamento	Citigroup	Neutral → Buy
2024-01-23	Iniziato	Morgan Stanley	Equal-Weight
2024-01-16	Ripresa	UBS	Buy
2024-01-03	Aggiornamento	Jefferies	Hold → Buy
2023-07-14	Iniziato	HSBC Securities	Reduce
2023-03-17	Aggiornamento	Deutsche Bank	Hold → Buy
2023-02-27	Ripresa	Goldman	Buy
2023-01-03	Downgrade	JP Morgan	Neutral → Underweight
2022-12-05	Downgrade	BofA Securities	Neutral → Underperform
2022-11-11	Downgrade	UBS	Neutral → Sell
2022-09-15	Aggiornamento	Credit Suisse	Underperform → Neutral
2022-09-08	Downgrade	Jefferies	Buy → Hold
2022-08-05	Ripresa	Morgan Stanley	Equal-Weight
2022-07-21	Ripresa	Citigroup	Neutral
2022-02-11	Downgrade	DZ Bank	Buy → Hold
2021-11-05	Aggiornamento	Barclays	Underweight → Equal Weight
2021-06-24	Aggiornamento	Deutsche Bank	Sell → Hold
2021-03-23	Downgrade	SVB Leerink	Outperform → Mkt Perform
2021-02-04	Downgrade	Deutsche Bank	Hold → Sell
2021-01-20	Downgrade	Credit Suisse	Neutral → Underperform
2021-01-15	Iniziato	Deutsche Bank	Hold
2020-11-02	Aggiornamento	Liberum	Hold → Buy
2020-09-29	Iniziato	Berenberg	Buy
2020-02-12	Downgrade	Shore Capital	Hold → Sell
2020-01-16	Downgrade	Barclays	Equal Weight → Underweight
2019-12-02	Iniziato	SVB Leerink	Outperform
2019-11-21	Aggiornamento	UBS	Neutral → Buy
2019-10-11	Aggiornamento	Cantor Fitzgerald	Hold → Buy
2019-09-03	Ripresa	Citigroup	Neutral
2019-09-03	Aggiornamento	Societe Generale	Sell → Buy
2019-08-13	Ripresa	JP Morgan	Neutral
2019-06-17	Ripresa	Morgan Stanley	Underweight
2019-03-08	Downgrade	Shore Capital	Buy → Hold
2019-02-22	Downgrade	UBS	Buy → Neutral
2019-01-14	Downgrade	Exane BNP Paribas	Outperform → Neutral
2018-12-11	Ripresa	Jefferies	Buy
2018-10-09	Iniziato	Guggenheim	Neutral
2018-08-30	Downgrade	Liberum	Buy → Hold
2018-04-04	Aggiornamento	Exane BNP Paribas	Neutral → Outperform
2018-03-22	Aggiornamento	Morgan Stanley	Underweight → Equal-Weight
2018-02-09	Aggiornamento	Kepler	Reduce → Hold